S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

PMVP PMV Pharmaceuticals Inc

1.57

0.04 (2.61%)

Last Updated: 03:46:28

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

PMV Pharmaceuticals (NASDAQ:PMVP)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more PMV Pharmaceuticals Charts.

PMV Pharmaceuticals (NASDAQ:PMVP)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more PMV Pharmaceuticals Charts.

PMV Pharmaceuticals Inc News

Form EFFECT - Notice of Effectiveness
Friday 29 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 28 November 2024 (1 month ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results
Friday 8 November 2024 (2 months ago) • GlobeNewswire Inc.

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial
Wednesday 23 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 September 2024 (4 months ago) • Edgar (US Regulatory)

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
Thursday 15 August 2024 (5 months ago) • Edgar (US Regulatory)

More PMV Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions